Document is current
Any future updates will be listed below
-
Authors
Perez, Tyson M. https://orcid.org/0000-0003-3054-5928
Glue, Paul
Adhia, Divya B.
Navid, Muhammad S.
Zeng, Jiaxu
Dillingham, Peter
Smith, Mark
Niazi, Imran K.
Young, Calvin K.
De Ridder, Dirk
- License Information
-
More Information
Article History
Received: 14 May 2021
Accepted: 22 October 2022
First Online: 17 November 2022
Declarations
:
: Ethical approval (19/CEN/179) has been obtained from the Health & Disability Ethics Committee (HDEC), New Zealand (see Additional file 3). Written, informed consent to participate will be obtained from all participants.
: Examples of the participant information and informed consent forms can be provided upon request.
: MS is the owner of Neurofeedback Therapy Services of New York which provides ISF-NFB therapy for patients and training for clinicians. He created the ISF-NFB software programs for this trial, provided guidance to the principal investigator in their utilization, and participated in editing of the final version of the manuscript. MS did not participate in the trial conceptualisation, design, implementation, or analyses. All other authors declare no competing interests.
